Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Synaffix B.V. maintains a portfolio in the Biotechnology & Pharmaceuticals technology area with 2 pending office actions currently active. These actions are spread across 2 distinct art units, which suggests the company's innovations touch upon different specialized classifications within the broader biotech field. The engagement with 2 distinct examiners indicates that each pending matter is being reviewed by a different individual at the patent office.
HUYNH, PHUONG N is the busiest examiner for the Synaffix B.V. portfolio, responsible for 1 pending office action. Since there are 2 pending office actions in total and 2 distinct examiners, the workload is distributed with each examiner managing a portion of the cases. This 1 pending office action represents the specific focus of the busiest examiner at this stage. Practitioners should note that the involvement of 2 distinct art units might require diverse technical arguments tailored to the specific standards of each unit to achieve successful outcomes.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CANELLA, KAREN A | 1 | 62.2% | +32.8% |
| HUYNH, PHUONG N | 1 | 65.7% | +53.6% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18116172 | METHODS FOR THE PREPARATION OF BIOCONJUGATES | HUYNH, PHUONG N | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18116172 | METHODS FOR THE PREPARATION OF BIOCONJUGATES | HUYNH, PHUONG N | 14d |
| 18087678 | METHODS FOR THE PREPARATION OF LINKER PAYLOAD CONSTRUCTS | PUTTLITZ, KARL J | 29d |
| 18121447 | ANTIBODY-EXATECAN CONJUGATES | CANELLA, KAREN A | — |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 1641 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18121447 | ANTIBODY-EXATECAN CONJUGATES | CANELLA, KAREN A | 1643 | §102§103§112DP | Non-Final OA | — | Pending | Mar 14, 2023 |
| 18116172 | METHODS FOR THE PREPARATION OF BIOCONJUGATES | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | 14d | Pending | Mar 01, 2023 |
| 18087678 | METHODS FOR THE PREPARATION OF LINKER PAYLOAD CONSTRUCTS | PUTTLITZ, KARL J | 1646 | §103 | Final Rejection | 29d | Pending | Dec 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial